Aspire Biopharma (ASBP) Holdings announced that its Board of Directors has authorized the repurchase of up to $5M of the Company’s common stock
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASBP:
- Aspire Biopharma closes final tranche of $21M private placement
- Aspire Biopharma Completes Financing, Advances Dura Control Acquisition
- Buzz Bomb brand ambassador to attempt fastest 100-mile treadmill run
- Aspire Biopharma Completes $21 Million Private Placement Financing
- Aspire Biopharma Shareholders Approve Major Capital Structure Changes